Sorry to hear that Jase.
Yes just doing the same as the T cell therapies, but with no safety issues is enough. And how many $10's billions do T cell therapies make each year?
But as the patient produces their own antibodies, there's also the theory that they will be more effective and more on-demand. Also patients are less likely to build a resistance to the treatment.
The evidence so far is that B cells are looking far superior to T cell therapies. And T cell therapies are a very valuable and growing market - which B cells could wipe out in a flash.
The value of imu's product is potentially seriously big.
cheers
A cure for cancer?, page-6
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |